Get the Stockscreener App
5.31
1.30%
-0.07
After Hours:
5.31
Sight Sciences Inc stock is traded at $5.31, with a volume of 251.38K.
It is down -1.30% in the last 24 hours and up +53.91% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
See More
Previous Close:
$5.38
Open:
$5.12
24h Volume:
251.38K
Relative Volume:
0.76
Market Cap:
$288.92M
Revenue:
$77.36M
Net Income/Loss:
$-38.43M
P/E Ratio:
-7.1679
EPS:
-0.7408
Net Cash Flow:
$-29.92M
1W Performance:
+25.83%
1M Performance:
+53.91%
6M Performance:
-24.57%
1Y Performance:
+72.40%
1-Day Range:
$5.12
$5.545
1-Week Range:
$4.15
$5.6613
52-Week Range:
$3.06
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.31 | 292.73M | 77.36M | -38.43M | -29.92M | -0.7408 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
Insiders At Sight Sciences Sold US$1.8m In Stock, Alluding To Potential Weakness - Moomoo
Sight Sciences(SGHT) Stock Options Chain | Quotes & News - Moomoo
Sight Sciences Financial Results for Q1 2026 Show Growth - VisionMonday.com
Sight Sciences Earnings Call Signals Disciplined Growth - TipRanks
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $12 - Moomoo
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2026 Earnings Call Transcript - Insider Monkey
Stifel Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Piper Sandler Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
Sight Sciences (SGHT) Q1 2026 Earnings Transcript - AOL.com
Sight Sciences Q1 Earnings Call Highlights - Yahoo Finance
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Sight Sciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sight Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance UK
SGHT: Double-digit revenue growth and raised guidance, with strong segment execution and patent win - TradingView
Earnings call transcript: Sight Sciences Q1 2026 revenue up, EPS misses - Investing.com
Sight Sciences Lifts 2026 Outlook After Strong Q1 - TipRanks
Sight Sciences (NASDAQ: SGHT) grows Q1 2026 sales and wins $55.4M judgment - Stock Titan
Sight Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Sight Sciences (NASDAQ: SGHT) boosts 2026 revenue outlook after strong Q1 - Stock Titan
BRIEF-Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million - TradingView
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance - ChartMill
Sight Sciences Q1 2026 Earnings Call Transcript - MarketBeat
Sight Sciences Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Sight Sciences Publishes Its 2025 Sustainability Report - VisionMonday.com
Sight Sciences to Present at Two Upcoming Investor Conferences - The Manila Times
Sight Sciences (SGHT) to Release Earnings on Wednesday - MarketBeat
Sight Sciences maps out two May investor conference appearances - Stock Titan
Sight Sciences Issues 2025 Sustainability Report on ESG Initiatives - VisionMonday.com
Sight Sciences awarded $55.4 million in patent case against Alcon By Investing.com - Investing.com Canada
Sight Sciences awarded $55.4 million in patent case against Alcon - Investing.com
Sight Sciences Wins Patent Judgment, Secures Ongoing Royalties - TipRanks
Sight Sciences (NASDAQ: SGHT) awarded $55.4M and 10% Hydrus royalty - Stock Titan
Sight Sciences Announces the Release of its Sustainability Report - The Manila Times
Sight Sciences (NASDAQ: SGHT) details 2026 meeting, director elections and auditor vote - Stock Titan
Sight Sciences will detail first-quarter results after market close May 6 - Stock Titan
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 - marketscreener.com
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sight Sciences wins $34M patent ruling against Alcon - MSN
KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus
SGHT: Momentum builds for interventional glaucoma and dry eye, with innovation and adoption accelerating - TradingView
If You Invested $1,000 in Sight Sciences, Inc. (SGHT) - Stock Titan
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Sight Sciences CFO Rodberg sells $25,670 in shares By Investing.com - Investing.com India
Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com Canada
Sight Sciences CLO Hayden sells shares worth $48,851 - Investing.com
Sight Sciences CFO Rodberg sells $25,670 in shares - Investing.com
Sight Sciences (NASDAQ:SGHT) CFO James Rodberg Sells 7,231 Shares of Stock - MarketBeat
Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):